It is too soon to tell whether the shots have a broad beneficial effect on patients with continuing issues, but scientists are intrigued and beginning to study the phenomenon.
Tag: Pfizer Inc
Hungary Pays $36 Per Dose for Chinese Vaccine
The European nation has agreed to pay $36 per dose of the Sinopharm vaccine, according to contracts put online by a Hungarian official.
The first vaccine vial used in the U.S. is added to the Smithsonian’s collection.
Amid efforts to amass items that document the pandemic, the National Museum of American History acquired the bottle used on Dec. 14 to inoculate Sandra Lindsay, a nurse at a Queens hospital.
Your Monday Briefing
Israel reopens to its vaccinated populace.
Pfizer Vaccine Will Be Tested Against Variant from South Africa
Scientists want to inoculate every adult in one Austrian district, in a real-world test of how the Pfizer-BioNTech vaccine works against the variant first seen in South Africa.
Plan to Ditch the Mask After Vaccination? Not So Fast.
It’s not clear how easily vaccinated people may spread the virus, but the answer to that question is coming soon. Until then, scientists urge caution.
Amid Slow Vaccine Deliveries, Desperate E.U. Nations Hunt for More
Countries eager to augment the troubled E.U. buying program are eyeing offers from each other, from Russia and China, and from private brokers, some of whom are fraudsters.
One Pfizer dose offers robust protection for those who have had Covid-19, studies find.
Two new pieces of research add strong evidence to the case for giving just a single dose of the Pfizer vaccine to people who have antibodies against the virus.
Germans Clamor for Covid Vaccines, but Shun AstraZeneca’s Offering
Hundreds of thousands of AstraZeneca doses are sitting unopened as many Germans reject the vaccine over fears it is “second-class” compared to the one developed by BioNTech and Pfizer.
Israel Study Says Pfizer Vaccine Is Very Effective in Real-World Use
A huge study in Israel found that the vaccine reduced symptomatic cases by 94 percent a week after the second dose, and reduced severe disease by 92 percent.